INTRODUCTION Alcohol-induced liver disease is the most common type of drug-induced liver disease. All other drugs together account for less than 10% of.

Slides:



Advertisements
Similar presentations
Diagnosis, management and prevention of drug-induced liver injury
Advertisements

RHY/CH00561 Biology of Disease CH0576 Hyperbilirubinaemia & Jaundice II.
Hepatic Disease Normal Anatomy andPhysiology. Hepatic: Normal Anatomy 1. Biliary system 2. Portal system 3. Reticulo-endothelial system 4. Hepatic parenchyma:
Chapter 15 The Liver The liver lies in the upper right quadrant of the abdominal cavity and is the largest organ in the body. The functions of the liver.
Fatal cirrhosis decompensation due to brucellosis: therapeutic issues. Maria Kosmidou, 1 Leonidas Christou 1 Markos Marangos, 2 Georgios Panos, 2 Epameinondas.
1 CLINICAL CHEMISTRY-2 (MLT 302) LIVER FUNCTION AND THE BILIARY TRACT LECTURE FOUR Dr. Essam H. Aljiffri.
Chronic liver disease.
Cirrhosis Biol E-163 TA session 1/8/06. Cirrhosis Fibrosis (accumulation of connective tissue) that progresses to cirrhosis Replacement of liver tissue.
Toxic Hepatocellular Injury Mike Contarino, MD Internal Medicine and Pediatrics 1/22/10.
PENICILLIN G PRESENT BY: ADEL T. AL-OHALI. Introduction: Penicillin G is one of the natural penicillins. it discover at 1929 and did not use until 1941.
CLINICAL CHEMISTRY-2 (MLT 302) LIVER FUNCTION AND THE BILIARY TRACT LECTURE FIVE Dr. Essam H. Aljiffri.
Acetaminophen is a non-narcotic analgesic, antipyretic, weak anti-inflammatory activity.  COX-3 in CNS   PGs (brain)  COX-3 in CNS   PGs (brain)
DR. SHABANA ALI. Adverse Drug Reactions (ADR) Harm associated with the use of a given medications OR Unwanted or harmful reaction experienced after the.
© 2007 Thomson - Wadsworth Chapter 19 Nutrition and Liver Diseases.
Iva Pitner Mentor: A. Žmegač Horvat
Liver failure.
Liver pathology: CIRRHOSIS
Chronic hepatitis in childhood Modes of presentation Acute onset jaundice and persisting Gradual development of signs of liver disease Asymptomatic finding.
Severe Paediatric Liver Conditions Acute liver failure Reye syndrome “Impila poisoning” Ascites Chronic liver disease Chronic hepatitis Hepatic schistosomiasis.
Metabolic diseases of the liver Central role in metabolism Causes and mechanisms of dysfunction Clinical patterns of metabolic disease Clinical approach.
Liver disease Prepared by: Siti Norhaiza Bt Hadzir.
Iron Toxicity. Overview Principle of the disease Clinical features Diagnosis management.
Hepatic Injury Induced By Drugs GAO Fen-Fei. Overview Liver ’ s pivotal role in the processing of foreign substances also makes it susceptible to injury.
 Fatty liver disease can range from fatty liver alone (steatosis) to fatty liver associated with inflammation (steatohepatitis). This condition can occur.
Nursing Care of Clients with Gallbladder, Liver and Pancreatic Disorders Chapter 27.
MLAB 2401: Clinical Chemistry Keri Brophy-Martinez Alterations in Liver Function.
39 yr old female pt, unemployed from Bloemfontein Routine follow up at rheumatology Background history of hypertension Diagnosis of ? Mixed connective.
Cause of disability. Changes in the joint inflammation, proliferation of the synovium, errosion of cartilage & bones.
 Hepatic Pathology and Respiratory System Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health.
Factors Affecting Drug Activity Chapter 11 Pages
Cholestatic Liver Disease Primary Biliary Cirrhosis.
Cholestatic liver diseases:
Prof JH van Zyl Central role of liver in drug metabolism 02. Principal reactions in drug metabolism 03. Electron flow pathway in the microsomal.
Drug-Induced Liver Injury (DILI) Professor Kassim Al-Saudi M.B.,Ch.B.,Ph.D.
Primary Sclerosing Cholangitis
Interpreting Your Liver Test Results Sumeet Asrani MD MSc Hepatologist Baylor University Medical Center, Dallas April 2015.
KEY TERMS DX TESTS RISK FACTORS CANCER PATHOPHYS HODGE-
Other causes of Cirrhosis: Genetic eg. Wilson's Disease, Hemochromatosis Autoimmune eg. Autoimmune Hepatitis, Primary Biliary Cirrhosis, Primary Sclerosing.
Quinolones Folic Acid Antagonists Urinary Tract Antiseptics.
Acetaminophen Toxicity. Overview Principle pf the disease Clinical features Diagnosis Management.
Cirrhosis Dr. Meg-angela Christi M. Amores. Cirrhosis a histopathologically defined condition – pathologic features consist of the development of fibrosis.
1 Adverse effect of drugs Excessive Pharmacologic Effects –overdoing the therapeutic effect –Atropine –muscarinic antagonist, desired therapeutic –Effect:
CIRRHOSIS.
Pathophysiology. Maximum therapeutic dose: - 4g in adults - 90mg/kg in children Toxicity is with single ingestion of 150 mg/kg or ~7-10 g (adult)
Complications of liver cirrhosis
Acute Viral Hepatitis Dr.Akhavan.
Dr. Ravi kant Assistant Professor Department of General Medicine.
This lecture was conducted during the Nephrology Unit Grand Ground by Nephrology Registrar under Nephrology Division, Department of Medicine in King Saud.
Exam review GIT and Liver, Gall bladder. Liver Hepatitis Circulatory diseases.
Hepatitis. Hepatitis * Definition: Hepatitis is necro-inflammatory liver disease characterized by the presence of inflammatory cells in in the portal.
Clinical History Patient presents with a palpable upper abdominal mass Patient states possible clinical history of abdominal hernia.
Gilead -Topics in Human Pathophysiology Fall 2009 Drug Safety and Public Health.
Digestive System Disorders By Adrienne, Lacey, and Lindsey.
PK 1 조 :: 조재완 DDx of jaundice. Jaundice: Introduction Jaundice - Yellowish discoloration : deposition of bilirubin – Serum hyperbilirubinemia – Liver.
Acetaminophen Intoxication Ali Labaf M.D. Assistant professor Department of Emergency Medicine Tehran University of Medical Science.
LIVER DAMAGE The majority of cases of liver damage are due to:
Budesonide induces remission more effectively than Prednisone in a controlled trial of patients with Autoimmune Hepatitis GASTROENTEROLOGY 2010;139:1198–1206.
Alcoholic Liver Disease Prof.Dr. Khalid A. Al-Khazraji MBCHB, CABM, FRCP, FACP Baghdad medical college
Hepatitis B virus infection in renal transplant recipients
Drug & Toxin-Induced Hepatic Disease
Drug Induced Liver Disease Tutoring
Liver Disease tutoring Part 1
The virus that does not cause chronic liver disease
Anticonvulsants: Valproic acid
Drug-induced liver injury part I
Non-alcoholic steatohepatitis with positive ANA
Orthotopic liver transplant, recurrent non-alcoholic steatohepatitis
Internal medicine L-4 Liver cirrhosis & portal hypertension
Acute (Fulminant) Hepatic Failure (FHF)
Presentation transcript:

INTRODUCTION Alcohol-induced liver disease is the most common type of drug-induced liver disease. All other drugs together account for less than 10% of patients hospitalized for elevated liver enzymes. In approximately 75% of these cases liver transplantation is ultimately required for patient survival.

PATTERNS OF DRUG-INDUCED LIVER DISEASE Idiosyncratic reactions Allergic hepatitis Toxic hepatitis Chronic active toxic hepatitis Toxic cirrhosis Liver vascular disorders

IDIOSYNCRATIC REACTIONS A genetic or acquired abnormality in a particular metabolic pathway. The reactions are typically associated with a drug concentration and often respond to simply lowering the dose of the drug. Idiosyncratic reactions tend to occur without association to particular blood concentrations or specifically identified metabolic abnormalities. For example, sulfonylureas like glipizide and antibiotics like ciprofloxacin

ALLERGIC HEPATITIS The reaction usually develops within 4 weeks of the start of therapy. It is marked by fever, pruritus, rash, eosinophilia, arthritis, and hemolytic anemia. The formation of granulomas within the liver is often seen on biopsy. Most antibiotics have been associated with this type of reaction, including the fluoroquinolones, macrolides, and β- lactams, trimethoprim, sulphamethoxazole, penicillin resistant penicillins.

TOXIC HEPATITIS When taken in overdose, acetaminophen becomes bioactivated to a toxic intermediate known as N-acetyl-p-benzoquinone imine (NAPQI). Reye’s syndrome is an aggressive form of toxic hepatitis often associated with aspirin use in children. Valproate toxicity can also present in this pattern In advanced stages of Reye’s syndrome, many patients develop intracranial hypertension that can be life threatening and refractory to therapy.

CHRONIC ACTIVE TOXIC HEPATITIS Patients experience periods of symptomatic hepatitis followed by periods of convalescence, only to repeatthe experience months later. It is a progressive disease with a high mortality rate and is more common in females than males. Antinuclear antibodies appear in most patients. These drugs appear to form antiorganelle antibodies. Diagnosis requires multiple episodes occurring long after exposure to the offending drug. Ex: Dantrolene, isoniazid, phenytoin, nitrofurantoin, and trazodone.

TOXIC CIRRHOSIS Hepatomegaly is a common finding, along with ascites and portal hypertension. Methotrexate (psoriasis and arthritis) Vit A toxicity.

LIVER VASCULAR DISORDERS Focal lesions in hepatic venules, sinusoids, and portal veins. Azathioprine and herbal teas that contain comfrey (a source of pyrrolizidine alkaloids) Peliosis hepatitis has been associated with exposure of the liver to androgens, estrogens, tamoxifen, azathioprine, and danazol. Rupture of the lacunae can lead to severe peritoneal hemorrhage.

MECHANISMS OF DRUG-INDUCED LIVER DISEASE CENTROLOBULAR NECROSIS Two types : Mild drug reactions : asymptomatic elevations in the serum transaminases. More severe forms : nausea, vomiting, upper abdominal pain, and jaundice.

STEATOHEPATITIS Tetracycline given intravenously and in doses greater than 1.5 g/day. (mortality 70% to 80%) Sodium valproate : Cytochrome P450 converts valproate to D-4-valproic acid, a potent inducer of microvesicular fat accumulation. PHOSPHOLIPIDOSIS Usually the phospholipidosis develops in patients treated for more than 1 year. The patient can present with either elevated transaminases or hepatomegaly; jaundice is rare. Ex: Amiodarone

GENERALIZED HEPATOCELLULAR NECROSIS Isoniazid and ketoconazole. CHOLESTATIC JAUNDICE The administration of total parenteral nutrition for periods greater than 1 week induces cholestatic changes and nonspecific enzyme elevations in some patients. Patients with low serum albumin concentrations may be at greater risk than patients with normal serum albumin concentrations. Rarely with sulfonamides, sulfonylureas, erythromycin estolate and ethylsuccinate, captopril, lisinopril, and other phenothiazines.

MIXED HEPATOCELLULAR NECROSIS AND CHOLESTATIC DISEASE Flutamide causes a mix of lesions that appear at or about the fortyeighth week of treatment. Niacin in doses greater than 3 g/day, or in doses greater than 1 g/day of sustained-release formulations, causes the same mixed pattern of damage. NEOPLASTIC DISEASE Both carcinoma- and sarcoma-like lesions have been identified. Lesions are associated with long-term exposure to the offending agent. Androgens, estrogens, and other hormonal-related agents.

ASSESSMENT Patient’s history Use of street drugs (cocaine, methylenedioxymethamphetamine – fulminant hepatitis) Occupational or environmental exposures A person’s use of alternative medicine must be solicited The nutritional status of a patient All potential drug reactions

MEASUREMENT OF LIVER FUNCTION MONITORING LFT’s Sulfobromophthalein or indocyanine-green excretion studies be performed on a regular basis Patients treated for very long periods of time should have a liver biopsy performed every 12 months.